---
title: "Schenkein David P — Ownership Dossier"
canonical: https://whiteintel.dev/entity/ea372b4e-63dc-555f-901a-3412fd49b904
json: https://whiteintel.dev/api/public/dossier/ea372b4e-63dc-555f-901a-3412fd49b904
identifier: sec:0001578200
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Schenkein David P

**Type:** Person  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001578200`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/ea372b4e-63dc-555f-901a-3412fd49b904  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/ea372b4e-63dc-555f-901a-3412fd49b904  

## Ownership & control

### Holdings / subsidiaries

- **REGENERON PHARMACEUTICALS, INC.** (director) — https://whiteintel.dev/entity/4c94c46c-66cf-5651-b60a-46242ce9fe83
- **Denali Therapeutics Inc.** (director) — https://whiteintel.dev/entity/73626793-468a-5743-a8c0-5b9d1bed32f4
- **Prime Medicine, Inc.** (director) — https://whiteintel.dev/entity/88ba017d-558f-5834-9839-6564794aca6f
- **REGENERON PHARMACEUTICALS, INC.** (director) — https://whiteintel.dev/entity/4c94c46c-66cf-5651-b60a-46242ce9fe83
- **AGIOS PHARMACEUTICALS, INC.** (director) — https://whiteintel.dev/entity/2c50afe3-b767-51de-9f1e-d25fda50bd09
- **bluebird bio, Inc.** (director) — https://whiteintel.dev/entity/2368d4d2-afa3-5231-9caf-a54123271869
- **AGIOS PHARMACEUTICALS, INC.** (officer) — https://whiteintel.dev/entity/2c50afe3-b767-51de-9f1e-d25fda50bd09
- **FOUNDATION MEDICINE, INC.** (director) — https://whiteintel.dev/entity/f68cd8e2-f33d-56d8-8778-0c137ae262c3
- **AGIOS PHARMACEUTICALS, INC.** (tenpercentowner) — https://whiteintel.dev/entity/2c50afe3-b767-51de-9f1e-d25fda50bd09

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Schenkein David P**. Human view: https://whiteintel.dev/entity/ea372b4e-63dc-555f-901a-3412fd49b904 · Structured JSON: https://whiteintel.dev/api/public/dossier/ea372b4e-63dc-555f-901a-3412fd49b904._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._